Sensitivity Analysis in Cost-Effectiveness Studies
暂无分享,去创建一个
[1] S. Pauker,et al. The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.
[2] A Briggs,et al. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. , 1994, Health economics.
[3] A H Briggs,et al. Handling uncertainty when performing economic evaluation of healthcare interventions. , 1999, Health technology assessment.
[4] M. Parsonage,et al. Discounting and health benefits. , 1992, Health economics.
[5] Andrew H Briggs,et al. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. , 2002, Annual review of public health.
[6] M F Drummond,et al. Users' Guides to the Medical Literature: XIII. How to Use an Article on Economic Analysis of Clinical Practice A. Are the Results of the Study Valid? , 1997 .
[7] David J. Pasta,et al. Probabilistic Sensitivity Analysis Incorporating the Bootstrap , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] Jing Jing Li,et al. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. , 2009, JAMA.
[9] A. Briggs,et al. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. , 2002, Health economics.
[10] B. Schackman,et al. How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions? , 2012, PharmacoEconomics.
[11] M. Weinstein,et al. Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.
[12] San Antonio. Annual Meeting of the Southwest Educational Research Association , 1999 .
[13] A. Briggs. Statistical approaches to handling uncertainty in health economic evaluation , 2004, European journal of gastroenterology & hepatology.
[14] A Briggs,et al. Sensitivity analysis in economic evaluation: a review of published studies. , 1995, Health economics.
[15] W. Edmunds,et al. Impact of Model, Methodological, and Parameter Uncertainty in the Economic Analysis of Vaccination Programs , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[16] J Lipscomb,et al. Time Preference for Health in Cost-Effectiveness Analysis , 1989, Medical care.
[17] P Barton,et al. Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. , 2009, Health technology assessment.
[18] J. B. Ramsey,et al. Tests for Specification Errors in Classical Linear Least‐Squares Regression Analysis , 1969 .
[19] Andrew H. Briggs,et al. Handling Uncertainty in Cost-Effectiveness Models , 2000, PharmacoEconomics.
[20] J. Richard Landis,et al. Large sample variance of kappa in the case of different sets of raters. , 1979 .
[21] Karl Claxton,et al. Assessing Quality in Decision Analytic Cost-Effectiveness Models , 2000, PharmacoEconomics.
[22] J. Seymour,et al. Raising the quality of cost-utility analyses: lessons learnt and still to learn. , 1999, Health policy.
[23] R. Engle. Autoregressive conditional heteroscedasticity with estimates of the variance of United Kingdom inflation , 1982 .
[24] Dennis G. Fryback,et al. Assessing the effectiveness of health interventions for cost-effectiveness analysis , 1997, Journal of General Internal Medicine.
[25] S. Goldfeld,et al. Some Tests for Homoscedasticity , 1965 .
[26] A F Lehman,et al. Cost-effectiveness of assertive community treatment for homeless persons with severe mental illness , 1999, British Journal of Psychiatry.
[27] S. R. Hill BMed PhD Fafphm,et al. Use of pharmacoeconomics in prescribing research. Part 5: modelling – beyond clinical trials , 2003 .
[28] M. Mcgrath. Cost Effectiveness in Health and Medicine. , 1998 .
[29] M G Myriam Hunink,et al. Uncertainty and Patient Heterogeneity in Medical Decision Models , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.
[30] B. McNeil,et al. Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.
[31] S Bryan,et al. The use of economic evaluations in NHS decision-making: a review and empirical investigation. , 2008, Health technology assessment.
[32] M. Drummond,et al. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. , 1997, JAMA.
[33] M. Sculpher,et al. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial. , 2008, Health technology assessment.
[34] S. Golder,et al. Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment , 2012, PharmacoEconomics.
[35] T. Breurch,et al. A simple test for heteroscedasticity and random coefficient variation (econometrica vol 47 , 1979 .
[36] Peter J. Neumann,et al. Using cost-effectiveness analysis to improve health care: opportunities and barriers. , 2004 .
[37] Anil K. Bera,et al. Efficient tests for normality, homoscedasticity and serial independence of regression residuals , 1980 .
[38] Javier Soto,et al. HEALTH ECONOMIC EVALUATIONS USING DECISION ANALYTIC MODELING , 2002, International Journal of Technology Assessment in Health Care.
[39] T. Einarson,et al. Sensitivity Analysis in Health Economic and Pharmacoeconomic Studies , 2012, PharmacoEconomics.
[40] R. Tibshirani,et al. The Measurement of Patients' Values in Medicine , 1982, Medical decision making : an international journal of the Society for Medical Decision Making.
[41] R. D'Agostino,et al. A Suggestion for Using Powerful and Informative Tests of Normality , 1990 .
[42] M. Drummond,et al. Economic Evaluation in Health Care: Merging Theory with Practice , 2002 .
[43] Mark Sculpher,et al. Subgroups and Heterogeneity in Cost-Effectiveness Analysis , 2012, PharmacoEconomics.
[44] Joachim Zietz. Heteroskedasticity and Neglected Parameter Heterogeneity , 2001 .
[45] Jeffrey M. Woodbridge. Econometric Analysis of Cross Section and Panel Data , 2002 .
[46] M. Goetghebeur,et al. Towards a European consensus on conducting and reporting health economic evaluations--a report from the ISPOR Inaugural European Conference. , 1999, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[47] Karl Claxton,et al. Characterizing structural uncertainty in decision analytic models: a review and application of methods. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[48] G A Colditz,et al. Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature , 1992, Annals of Internal Medicine.
[49] C. Dewa,et al. Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions , 2012, PharmacoEconomics.
[50] A E Ades,et al. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. , 2006, Health economics.
[51] Jeong-Wook Seo,et al. The Korean journal of pathology is selected for coverage in science citation index expanded and journal citation reports by Thomson Reuters , 2008 .
[52] Milton C Weinstein,et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[53] S. Sonnad,et al. Methodologic Quality of Cost-Effectiveness Analyses of Surgical Procedures , 2007, Annals of surgery.
[54] S Bryan,et al. Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness. , 2009, Health technology assessment.
[55] J Hjelmgren,et al. Health economic guidelines--similarities, differences and some implications. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[56] T O Jefferson,et al. Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.
[57] G. Torrance. Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.
[58] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[59] Joachim Zietz. Detecting neglected parameter heterogeneity with Chow tests , 2006 .
[60] C. Bell,et al. The Quality of Reporting in Published Cost-Utility Analyses, 19761997 , 2000, Annals of Internal Medicine.
[61] R. Lopert,et al. Use of pharmacoeconomics in prescribing research. Part 5: modelling – beyond clinical trials , 2003, Journal of clinical pharmacy and therapeutics.